南财智讯8月24日电，药明合联（02268.HK）公告，截至2026年6月30日止六个月实现收益37.01亿元人民币，毛利13.71亿元人民币，同比增长40.6%；期内溢利（即净利润）8.18亿元人民币，同比增长9.70%（2025年同期为7.46亿元人民币）；基本每股盈利0.65元人民币。（文章来源：南方财经网）
Source Link南财智讯8月24日电，药明合联（02268.HK）公告，截至2026年6月30日止六个月实现收益37.01亿元人民币，毛利13.71亿元人民币，同比增长40.6%；期内溢利（即净利润）8.18亿元人民币，同比增长9.70%（2025年同期为7.46亿元人民币）；基本每股盈利0.65元人民币。（文章来源：南方财经网）
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.